Create issue ticket

3,601 Possible Causes for 3C, A, Hepatitis, protease,, Virus

Show results in: Română

  • Influenza

    Virions containing seven RNPs arranged in the “1 6” configuration were also found for both D/Yamagata and C/AA ( Fig. 3C , D , G , and H ).[doi.org] Virulent avian influenza strains, which cause systemic disease, have an HA that is cleaved by proteases present in all cells of the body, rather than by proteases restricted[ncbi.nlm.nih.gov] Keywords Influenza Virus Sialic Acid Membrane Fusion Avian Influenza Virus Glycosidic Linkage These keywords were added by machine and not by the authors.[dx.doi.org] Author information 1 Department of Virology, Angers University Hospital, HIFIH Laboratory (Hemodynamics, Interaction Fibrosis and Invasiveness Hepatic Tumor), UBL (Université[ncbi.nlm.nih.gov] Among the 73 A(H3N2) viruses that were tested by sequencing or pyrosequencing, 34 (47%) were of hemagglutinin group 3C.2a, and 39 (53%) were of group 3C.3a.[nejm.org]

    Missing: A
  • Infectious Mononucleosis

    […] tetramer staining performed as previously described. 17 , 18 The following peptides were used: HLA A2–restricted peptides: A2 BRLF1–1/YVLDHLIVV, A2 BMLF1/GLCTLVAML, and A2 EBNA-3C[doi.org] Epstein-Barr virus (EBV), also known as human herpesvirus 4, is a member of the herpes virus family. It is one of the most common human viruses.[cdc.gov] […] concomitantly infected with hepatitis A.[ncbi.nlm.nih.gov] Another method of distinction called Ebnotyping distinguishes strains based on the size pattern of EBNA1, EBNA2, and EBNA3A, -3B, and -3C, which all contain repeat elements[doi.org] There are two subtypes of EBV, which differ from each other at the EBV nuclear antigen (EBNA) loci for EBNA2, -3A, -3B, and -3C ( 175 ).[doi.org]

    Missing: A protease
  • Lopinavir-Ritonavir

    86.1%) 70 (88.6%) Age, years B 39.92 (10.0) 40.44 (9.9) Karnofsky score (100) A 61 (84.7%) 68 (85.0%) CD4 cell count,/mm 3B 244.77 (123.7) 200.74 (117) CD4 cell count,/mm 3C[omicsonline.org] OBJECTIVE: PI susceptibility results from a complex interplay between protease and Gag proteins, with Gag showing wide variation across HIV-1 subtypes.[ncbi.nlm.nih.gov] Abstract We compared primary Epstein-Barr virus (EBV) infection and suppression between Kenyan human immunodeficiency virus-infected infants starting nevirapine-based vs lopinavir[ncbi.nlm.nih.gov] […] without hepatic impairment.[ncbi.nlm.nih.gov] OBJECTIVES: Major protease mutations are rarely observed following first-line failure with PIs and interpretation of genotyping results in this context may be difficult.[ncbi.nlm.nih.gov]

    Missing: A
  • Indinavir

    […] significantly greater at each time point in the group treated with indinavir (P The plasma HIV-1 RNA responses according to the CD4 cell count are shown in Figure 3B and Figure 3C[doi.org] OBJECTIVES: To report the association between the protease inhibitor indinavir and the development of urolithiasis.[ncbi.nlm.nih.gov] Abstract We report the first case of acute cholecystitis due to indinavir-induced cholelithiasis in a patient infected with human immunodeficiency virus who had been receiving[ncbi.nlm.nih.gov] RESULTS: Indinavir significantly inhibited hepatic and first-pass CYP3A activity.[ncbi.nlm.nih.gov] Abstract Human immunodeficiency virus-infected women (n 16) received indinavir (800 mg three times a day) plus zidovudine plus lamivudine from 14 to 28 weeks of gestation[ncbi.nlm.nih.gov]

    Missing: A
  • Hepatitis C Virus

    However, the introduction of the p7(KRAA) mutation into the ΔE1E2 mutant significantly reduced the interaction between NS2 and NS3 (Fig. 3C ).[ncbi.nlm.nih.gov] KEYWORDS: Direct-acting antiviral; HIV; NS3/4A protease inhibitor; hepatitis C[ncbi.nlm.nih.gov] Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo . J.[doi.org] Since 1998 it has been possible to screen for the… Read More cause of hepatitis C In hepatitis: Hepatitis C Hepatitis C virus (HCV) was isolated in 1988.[britannica.com] We detected gold-labeled spherical structures with an electron-dense inner core using a concentrated virus preparation ( Fig. 3c–e ), whereas we found only unstructured aggregates[ncbi.nlm.nih.gov]

    Missing: A
  • Hepatitis A Virus

    The purpose of this study was to explore the cytotoxic effect observed after co-expression of hepatitis A virus 3C protease (3C) and yeast cytosine deaminase/uracil phosphoribosyltransferase[ncbi.nlm.nih.gov] virus.[ncbi.nlm.nih.gov] Hepatitis A virus infection is one of probably several triggers that may induce autoimmune hepatitis in predisposed individuals.[ncbi.nlm.nih.gov] Protease 3C: Cysteine protease that generates mature viral proteins from the precursor polyprotein (PubMed: 1850033 ).[uniprot.org] KEYWORDS: Aichi virus; Cranberry juice; Hepatitis A virus; Titer reduction[ncbi.nlm.nih.gov]

    Missing: A
  • Hepatitis C

    Although the initial version of InnoLipa had lower sensitivity, the newer version is capable of discriminating among HCV subtypes 1a, 1b, 2a to 2c, 3a to 3c, 4a to 4h, 5a,[dx.doi.org] Single dose pharmacokinetics of a novel hepatitis C protease inhibitor, SCH 503034, in an oral capsule formulation (abstract 862) .[doi.org] Abstract Hepatitis C virus (HCV) is a blood-borne virus that is transmitted most efficiently by direct percutaneous exposures to blood.[doi.org] A infectious hepatitis virus - see Hepatitis, viral, type A serum hepatitis virus - see Hepatitis, viral, type B SH - see Hepatitis, viral, type B specified type NEC 070.59[icd9data.com] Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease .[doi.org]

    Missing: A
  • Nevirapine

    Briefly, we generated a FRET RT construct that allowed us to site-specifically label the fingers (T139C) and thumb (D250C) of p66 with Cy3 and Cy5 dyes (Figure 3C ).[nar.oxfordjournals.org] OBJECTIVES: An observational, prospective, cohort study was performed to compare efficacy and safety of a switch from ritonavir-boosted protease inhibitor (PI/r) to nevirapine[ncbi.nlm.nih.gov] Abstract Vertical infection of drug-resistant human immunodeficiency virus type 1 (HIV-1) has occasionally been reported in children from pretreated mothers with HIV-1 infection[ncbi.nlm.nih.gov] Abstract The aetiology of hepatic dysfunction in patients with HIV infection is multifactorial.[ncbi.nlm.nih.gov] Abstract Antiretrovirals from three drug classes, nucleoside analogs, nonnucleoside analogs, and protease inhibitors, can be combined to achieve viral suppression.[ncbi.nlm.nih.gov]

    Missing: A
  • Hepatitis A

    The purpose of this study was to explore the cytotoxic effect observed after co-expression of hepatitis A virus 3C protease (3C) and yeast cytosine deaminase/uracil phosphoribosyltransferase[ncbi.nlm.nih.gov] Abstract Hepatitis A virus (HAV) is one of the most common infectious etiologies of acute hepatitis worldwide.[ncbi.nlm.nih.gov] Convert to ICD-10-CM : 070.0 converts directly to: 2015/16 ICD-10-CM B15.0 Hepatitis A with hepatic coma Approximate Synonyms Hepatitis A with hepatic coma Hepatitis a, w[icd9data.com] Maturation of provirions by an unknown host protease.[viralzone.expasy.org] Hepatitis A virus (HAV) is transmitted by the fecal-oral route.[ncbi.nlm.nih.gov]

    Missing: A
  • Tenofovir

    , whereas the rates in the TDF group at 6, 12, 24 and 36 months were 37%, 73%, 84% and 91%, respectively, with significant difference between two groups ( P  0.035, Fig. 3c[bmcgastroenterol.biomedcentral.com] […] the efficacy and safety of switching to a single-tablet regimen of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide versus continuing a regimen of boosted protease[ncbi.nlm.nih.gov] BACKGROUND: Hepatitis B virus (HBV) reactivation in patients with resolved HBV infection (HBsAg negative, antiHBc positive) is uncommon, but potentially fatal.[ncbi.nlm.nih.gov] hepatitis B immune globulin.[ncbi.nlm.nih.gov] […] exposure, 71% completed the 28-day Quad pill regimen, which was significantly greater than historical controls who used TDF/FTC and raltegravir (57%, P 0.05) or AZT/3TC plus a protease[ncbi.nlm.nih.gov]

    Missing: A

Similar symptoms